Numerical targets under the Sixth Five-Year Medium-Term Management Plan
First written in FY2019. 2 of 5 entries say "Softened", first in FY2023. Latest entry: FY2024.
Nippon Shinyaku moved to the "Worse" side of this theme in 2023, 2 years after the typical company in this theme (2021).
The whole theme swung hardest in 2023: 3 of 8 companies on the "Worse" side.
2 other companies' latest entry also says "Softened".
- FY2024SoftenedAnnual report
「Under the Sixth Five-Year Medium-Term Management Plan, which began in fiscal 2019, the quantitative targets were not achieved due to factors including annual drug price revisions and the global spread of COVID-19. However, we launched at least 1 new product on average each year, began selling our own products in the United States, advanced the development of our global platform, and achieved record-high sales and profit in the final year of the Sixth Medium-Term Management Plan.」
While confirming that the quantitative targets of the Sixth Medium-Term Management Plan were not achieved, it states that new products were launched, own-product sales began in the United States, and record-high sales and profit were achieved. - FY2023SoftenedAnnual report
「Under the Sixth Five-Year Medium-Term Management Plan, which began in fiscal 2019, we targeted net sales of ¥150 billion, operating profit of ¥40 billion, profit for the year attributable to owners of the parent of ¥30 billion, EPS (basic earnings per share) of ¥445, and ROE (profit for the year attributable to owners of the parent divided by equity attributable to owners of the parent) of at least 10% for fiscal 2023, the final year of the plan. However, due to the impact of the COVID-19 pandemic and the interim-year revision of drug prices, among other factors, we expect to fall short of the numerical targets set when the plan was formulated, except for ROE.」
Regarding the final-year targets of the Sixth Medium-Term Management Plan, it was stated that the numerical targets are expected to be missed except for ROE, and the fiscal 2023 forecast was set at net sales of ¥145 billion, operating profit of ¥32 billion, and profit attributable to owners of the parent of ¥25 billion. - FY2021Added the third-year forecastAnnual report
「For the consolidated forecast for the fiscal year ending March 2022, the third year of the plan, we anticipate net sales of ¥135 billion, operating profit of ¥28 billion, and profit for the year attributable to owners of the parent of ¥21 billion.」
In addition to the targets for the final year of the Sixth Medium-Term Management Plan, the consolidated forecast for the third year, the fiscal year ending March 2022, was presented. - FY2020Added the interim-year forecastAnnual report
「For the consolidated forecast for the fiscal year ending March 2021, the second year of the plan, we anticipate net sales of ¥126 billion, operating profit of ¥25 billion, and profit for the year attributable to owners of the parent of ¥19 billion.」
In addition to the targets for the final year of the Sixth Medium-Term Management Plan, the consolidated forecast for net sales, operating profit and profit for the year for the second year, the fiscal year ending March 2021, was presented. - FY2019First statedAnnual report
「For the fiscal year ending March 2024, the final year of the Sixth Five-Year Medium-Term Management Plan (fiscal years ending March 2020 to March 2024), we are targeting net sales of ¥150 billion, operating profit of ¥40 billion, profit for the year attributable to owners of the parent of ¥30 billion, EPS (earnings per share) of ¥445, and ROE (return on equity) of at least 10%.」
The numerical targets for net sales, profit, EPS and ROE through the fiscal year ending March 2024 were presented for the first time under the Sixth Medium-Term Management Plan.